SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 17th, 2018 • Summit Therapeutics PLC • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 14, 2018 by and among Summit Therapeutics plc, a public limited company incorporated in England and Wales with the Registrar of Companies of England and Wales, with its principal place of business at 136a Eastern Avenue, Milton Park, Abingdon, Oxfordshire OX14 4SB, United Kingdom (the “Company”), and the investor named on Exhibit A hereto (the “Investor”).
DATE: DECEMBER 14, 2018 RELATIONSHIP AGREEMENT RELATING TO SUMMIT THERAPEUTICS PLC Between SUMMIT THERAPEUTICS PLC and ROBERT W. DUGGAN and CAIRN FINANCIAL ADVISERS LLP CMS Cameron McKenna Nabarro Olswang LLP Cannon Place London EC4N 6AF T +44 20 7367...Relationship Agreement • December 17th, 2018 • Summit Therapeutics PLC • Pharmaceutical preparations • England and Wales
